Skip to content
  • Sunday, 26 July 2026
  • 2:50 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Higher Consumption of Sugar Substitutes Linked to Accelerated Cognitive Decline and Memory Loss in Middle-Aged Adults
Neuroscience & Brain Research

Higher Consumption of Sugar Substitutes Linked to Accelerated Cognitive Decline and Memory Loss in Middle-Aged Adults

Rifan Muazin Jul 19, 2026 0

A longitudinal study published in Neurology, the medical journal of the American Academy of Neurology, has identified a significant association…

Read More
Neuroscience & Brain Research

The American Midlife Crisis: Why Middle-Aged Adults in the United States Are Falling Behind Their Global Peers in Health and Well-Being

Rifan Muazin Jun 14, 2026 0

For decades, the concept of the "midlife crisis" in the United States was synonymous with a sudden desire for a…

Read More
Neuroscience & Brain Research

Sex Differences in Modifiable Risk Factors of Dementia and Their Impact on Cognitive Function in Middle-Aged and Older Adults

Rifan Muazin May 20, 2026 0

New research from the University of California San Diego School of Medicine has revealed that women may be significantly more…

Read More
Pharmaceutical R&D

Filspari Secures Landmark FDA Approval for Focal Segmental Glomerulosclerosis (FSGS) in Adults and Pediatric Patients Aged Eight and Above

Teuku Ryan Apr 14, 2026 0

Travere Therapeutics has achieved a significant milestone in the treatment of rare kidney diseases with the U.S. Food and Drug…

Read More
Science News: A Century of Empowering Public Understanding of ScienceNovartis Navigates Generics Storm in Q1, Eyes Robust Future Fueled by Strategic Acquisitions and Pipeline AdvancementsUnlocking Deep Time: Ancient Regulatory DNA Rewrites Plant EvolutionUCB Acquires Candid Therapeutics for Up to $2.2 Billion to Bolster Autoimmune Disease Pipeline with Novel T-Cell Engagers
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ